Expert nurse practitioner Beth Faiman discusses evidence-based recommendations for how best to incorporate new therapeutic options for patients with chronic lymphocytic leukemia and mantle cell lymphoma.
NPs and PAs in oncology
This activity is supported an educational grant from AstraZeneca.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
Beth Faiman PhD, MSN, APRN-BC, AOCN has no relevant financial relationships to disclose.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 104922O-CT1